rs1555696603
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_001365902.3(NFIX):c.346C>T(p.Arg116Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R116P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001365902.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFIX | NM_001365902.3 | c.346C>T | p.Arg116Trp | missense_variant | 2/11 | ENST00000592199.6 | NP_001352831.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Malan overgrowth syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München | Aug 25, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Randwick Genomics Laboratory, Prince of Wales Hospital Sydney, Australia, New South Wales Health Pathology | - | PS2, PM1, PM2, PM5, PS4_moderate, PP2, PP3 - |
NFIX-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 03, 2023 | The NFIX c.346C>T variant is predicted to result in the amino acid substitution p.Arg116Trp. This variant has been reported as a de novo finding in multiple individuals diagnosed with NFIX related disorders including Malan syndrome (Hancarova et al. 2019. PubMed ID: 31369202; Lecoquierre et al. 2019. PubMed ID: 31036916; Tatton-Brown et al. 2017. PubMed ID: 28475857). Additionally, three alternate missense variants at this position have been reported in affected individuals, with some cases being de novo (p.Arg116Pro, p.Arg116Gln, p.Arg116Gly; Alternate nomenclature: NM_001271043.2:c.370C>T (p.Arg124Trp); Human Gene Mutation Database). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 17, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31036916, 31369202, 22982744, 35970915, 28475857) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at